Fisher & Paykel Healthcare Corporation Limited attaches a copy of its presentation to investors in Hong Kong, at the Goldman Sachs Investment Conference in London and at the Bank of America Merrill Lynch Investment Conference in New York.
The presentation will also be made available on the company’s website at http://www.fphcare.co.nz/investor/presentations.
Contact: Marcus Driller, General Manager Corporate on +64 9 574 0110. For more information about the company visit our website www.fphcare.com.
FPH Presentation to Investors in Hong Kong, London & New York
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Providing Optimal Humidity for intubated patients
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment